alendronate has been researched along with angiotensin ii in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, SJ; Li, L; Ye, Y | 1 |
| Chen, GP; Hu, SJ; Mou, Y; Yang, J; Ye, Y; Zhao, CZ; Zhu, HH | 1 |
| Chen, SQ; Fu, GS; Jiang, CY; Lv, X; Wang, MH; Ye, Y; Zhu, J | 1 |
3 other study(ies) available for alendronate and angiotensin ii
| Article | Year |
|---|---|
Inhibition of farnesylpyrophosphate synthase prevents angiotensin II-induced hypertrophic responses in rat neonatal cardiomyocytes: involvement of the RhoA/Rho kinase pathway.
Topics: Alendronate; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Dimethylallyltranstransferase; Hypertrophy; Myocytes, Cardiac; Prenylation; Rats; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction | 2009 |
Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced cardiac hypertrophy and fibrosis in vivo.
Topics: Alendronate; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Contraindications; Fibrosis; Gene Expression Regulation; Geranyltranstransferase; Humans; Male; Mice; Myocytes, Cardiac; Natriuretic Peptide, Brain; p38 Mitogen-Activated Protein Kinases; rho GTP-Binding Proteins; rhoA GTP-Binding Protein; Signal Transduction; Terpenes; Transforming Growth Factor beta1 | 2013 |
Alendronate prevents angiotensin II-induced collagen I production through geranylgeranylation-dependent RhoA/Rho kinase activation in cardiac fibroblasts.
Topics: Alendronate; Angiotensin II; Animals; Cells, Cultured; Collagen Type I; Depression, Chemical; Diterpenes; Dose-Response Relationship, Drug; Enzyme Activation; Fibroblasts; Fibrosis; Male; Molecular Targeted Therapy; Myocardium; Rats, Wistar; rho-Associated Kinases; Signal Transduction | 2015 |